Simcere Pharmaceutical Group Eulerpool Ziņas

Simcere Pharmaceutical Group Akciju Ziņas

Simcere Pharmaceutical Group tiek uzmanīgi vēroti no žurnālistu un investoru puses visā pasaulē. Jaunākās Simcere Pharmaceutical Group ziņas mēs apkopojam šeit.

• 30. oktobris ·

  Yahoo
  World Stroke Congress | TASTE-2 significantly reduces stroke disability
• 25. oktobris ·

  Yahoo
  TASTE-2 World Stroke Congress | Sanbexin ® combined with thrombectomy significantly reduces stroke disability
• 14. septembris ·

  Yahoo
  Breakthrough Therapy designation for Sanbexin sublingual tablets granted by the United States Food and Drug Administration
• 8. septembris ·

  SeekingAlpha
  Week In Review: EpimAb Sells T-Cell Engager In $635m Deal
• 5. septembris ·

  Yahoo
  Breakthrough Therapy designation for Sanbexin sublingual tablets granted by the United States Food and Drug Administration
• 2. septembris ·

  Yahoo
  Simcere Zaiming collaborates with TargetRx to introduce a third-generation ALK inhibitor
• 26. jūnijs ·

  Yahoo
  Simcere Zaiming Announce Approval of Cetuximab Beta in China by the NMPA